Evidence-based articles, treatment guides, and the latest news in addiction recovery and mental health.
A legal battle over Philadelphia's plan to use opioid settlement funds for neighborhood revitalization raises fundamental questions about how communities should spend billions in recovery dollars.
Achieve Life Sciences assembles veteran pharmaceutical leadership team from Verona Pharma ahead of FDA decision on cytisinicline, the first novel smoking cessation therapy since 2006.
NIH-funded research reveals how oral GLP-1 medications penetrate deep into brain reward circuits, offering new pathways for treating substance use disorders beyond weight loss.
CDC study reveals gabapentin detection in overdose deaths increased significantly, with 85-90% of cases also involving opioids
Kentucky reports lowest overdose death toll since 2014, with 1,101 fatalities representing 50% decrease from 2021 peak
New research reveals 21% of opioid overdose survivors experience repeat overdoses within a year—far exceeding previous estimates—as fentanyl transforms the crisis landscape.
Forty-two addiction specialists establish consensus best practices for initiating medications for opioid use disorder in hospitals, adapting protocols for the fentanyl era.
Research identifies novel mechanism where oral GLP-1 medications penetrate deep into brain's reward center, opening potential pathways for treating addiction
JAMA study finds psychedelic-assisted therapy produced higher abstinence rates and longer relapse prevention than standard treatment